Literature DB >> 9027645

Consecutive evaluation of immunoglobulin M and G antibodies against hepatitis E virus.

W M Ke1, D Tan, J G Li, S Izumi, Y Shinji, H Hotta, J L Yao.   

Abstract

Hepatitis E virus (HEV) infection is sporadic in the Guangzhou city southern China. However, the evaluation of antibodies to HEV during consecutive time periods after infection has not been reported. We utilized enzyme immunosorbent assay (ELISA) to defect IgM and IgG anti-HEV in consecutive serum specimens from patients with acute hepatitis E and compared that data with detection rates of IgM and IgG anti-HAV in patients with acute hepatitis A. IgM anti-HEV can be detected as early as 4 days after onset of disease symptoms in some patients. The detection rate of IgM anti-HEV is significantly higher in specimens collected within 4 weeks (95%) of onset than in those specimens collected 4 to 18 weeks after onset (67.6%) (P < 0.005). IgM anti-HEV had a similar pattern to IgM anti-HAV and can be used as a marker of acute HEV infection. In contrast with IgG anti-HAV, 56.8% of the specimens did not contain detectable levels of IgG anti-HEV (P < 0.005). One should be cautioned against making a diagnosis of HEV infection solely by the currently available assays for IgG anti-HEV. In conclusion, IgM anti-HEV can be used as a reliable and sensitive marker for recent HEV infection, but serum specimens should be collected within 4 weeks after onset of symptoms to avoid false-negative results. In contrast, we should be aware of the failure to develop IgG anti-HEV in some patients. These patients carry the risk of reinfection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027645     DOI: 10.1007/bf02358608

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  25 in total

1.  Hepatitis E and long-term antibody status.

Authors:  M S Khuroo; S Kamili; M Y Dar; R Moecklii; S Jameel
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

2.  Hepatitis E virus in Chile.

Authors:  H V Ibarra; S G Riedemann; F G Siegel; G V Reinhardt; C A Toledo; G Frösner
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

3.  Evidence for viral hepatitis other than type A or type B among persons in Costa Rica.

Authors:  V M Villarejos; K A Visoná; C A Eduarte; P J Provost; M R Hilleman
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

4.  Hepatitis E virus: identification of type-common epitopes.

Authors:  P O Yarbough; A W Tam; K E Fry; K Krawczynski; K A McCaustland; D W Bradley; G R Reyes
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus.

Authors:  V A Arankalle; M S Chadha; L P Chobe; R Nair; K Banerjee
Journal:  J Med Virol       Date:  1995-08       Impact factor: 2.327

6.  Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays.

Authors:  A S Lok; W K Kwan; R Moeckli; P O Yarbough; R T Chan; G R Reyes; C L Lai; H T Chung; T S Lai
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

7.  Hepatitis E virus transmission to a volunteer.

Authors:  A Chauhan; S Jameel; J B Dilawari; Y K Chawla; U Kaur; N K Ganguly
Journal:  Lancet       Date:  1993-01-16       Impact factor: 79.321

8.  Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction.

Authors:  S Jameel; H Durgapal; C M Habibullah; M S Khuroo; S K Panda
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

9.  Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

Authors:  R Goldsmith; P O Yarbough; G R Reyes; K E Fry; K A Gabor; M Kamel; S Zakaria; S Amer; Y Gaffar
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

10.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

View more
  3 in total

1.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

Review 2.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

3.  Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.

Authors:  Li Zhang; Zechun Jiang; Jingjing Lv; Jiaye Liu; Bingyu Yan; Yi Feng; Li Li; Guomin Zhang; Fuzhen Wang; Aiqiang Xu
Journal:  BMC Infect Dis       Date:  2018-02-12       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.